Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation... Show more
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BME declined for three days, in 214 of 281 cases, the price declined further within the following month. The odds of a continued downward trend are 76%.
The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BME as a result. In 59 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for BME turned negative on August 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 38 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
BME moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The RSI Indicator entered the oversold zone -- be on the watch for BME's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +1.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where BME advanced for three days, in 275 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
BME may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 201 of 242 cases where BME Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows